Results 141 to 150 of about 527 (153)

Comparative evaluation of disc diffusion and Liofilchem™ MTS strip methods with broth microdilution for cefepime/enmetazobactam susceptibility testing

Journal of Antimicrobial Chemotherapy
Abstract Background Cefepime/enmetazobactam is a newly approved β-lactam/β-lactamase inhibitor combination with promising activity against MDR Gram-negative Enterobacterales, particularly ESBL- and OXA-48-producing isolates.
Cécile Emeraud, Hippolyte De Swardt, Sandrine Bernabeu, Lena Latour, Alice Pages, Sarah Ronsin, Rémy A Bonnin, Laurent Dortet   +7 more
openaire   +2 more sources

Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis—Reply

JAMA, 2023
Keith S, Kaye, Adam, Belley, Patrick, Velicitat   +2 more
openaire   +2 more sources

Cefepime/enmetazobactam. β-Lactam/β-lactamase inhibitor, Treatment of complicated urinary tract infection

Drugs of the Future, 2022
Abdul Akhir, Arunava Dasgupta, Sidharth Chopra   +2 more
openaire   +1 more source

In-vitro activity of cefepime/enmetazobactam against extended spectrum beta-lactamases and/or ampC producing Enterobacterales and Pseudomonas aeruginosa collected across India

Diagnostic Microbiology and Infectious Disease
Yamuna Devi Bakthavatchalam, Abirami Shankar, Fiza Abdullah, Devishree Srinivasan, Harathi Ragothaman, Soniya KrishnaMoorthy, Yuvasri Manokaran, Senthur Nambi, V. Ramasubramanian, Vasanth Nagvekar, Abi Manesh, Rajiv Karthik, George M. Varghese, Deepak Kumar, Vikas Deswal, Hariharan Dwarakanathan, Santhosh Raj, Camilla Rodrigues, Rajeev Soman, Subash Todi, Dhanalakshmi Solaimalai, Balaji Veeraraghavan   +21 more
exaly   +2 more sources

Cefepime/Enmetazobactam Is a Clinically Effective Combination Targeting AmpC‐Producing Enterobacterales

Advanced Therapeutics, 2022
openaire   +1 more source

‘In vitro activity of cefepime-enmetazobactam on carbapenem-resistant gram negatives’—author's response

Clinical Microbiology and Infection
Rémy A, Bonnin, Katy, Jeannot, Anne, Santerre Henriksen, Juan, Quevedo, Laurent, Dortet   +4 more
openaire   +2 more sources

Enmetazobactam: an extended-spectrum beta-lactamase inhibitor in countering antimicrobial resistance

Jagatkumar Rajendrakumar Upadhyay, Anuradha Ketan Gajjar, Avani Chokshi   +2 more
openaire   +1 more source

Re: ‘In vitro activity of cefepime-enmetazobactam on carbapenem-resistant gram negatives’ by Bonnin et al.

Clinical Microbiology and Infection
Christophe, Le Terrier, Stuart, Shapiro, Patrice, Nordmann, Laurent, Poirel   +3 more
openaire   +2 more sources

Cefepim/Enmetazobactam (bakterielle Infektionen, mehrere Anwendungsgebiete); Addendum zum Projekt G24-15

openaire   +1 more source

In vitro activity of cefepime/enmetazobactam against Klebsiella pneumoniae carrying blaKPC allelic variants conferring resistance to ceftazidime/avibactam

International Journal of Antimicrobial Agents
Luca Caiazzo, Edoardo Carretto, Paolo Gaibani   +2 more
openaire   +1 more source